Prof. John Greenspan, BSc, BDS, Ph.D, FRCPath, ScD, FDRCS (ENG), FKC is a Professor and Associate Dean for Global Oral Health, and a Distinguished Professor of Pathology in the School of Dentistry and Medicine, University of California San Francisco (UCSF). His research interest centres on the epidemiology, etiopathogenesis and management of oral soft tissue diseases, notably those associated with HIV infection and other causes of immunosuppression, as well as aphthous ulcers, Sjögren's syndrome, and oral cancer/pre-cancer. He has worked on the epidemiologic and genetic studies on Sjögren's Syndrome, as well as continuing the expansion of translational research on HIV in across basic, clinical, and behavioural sciences. He has co-authored a study on the natural history and pathogenesis of HIV-infection in a large cohort of women at risk for AIDS in the San Francisco Bay Area. He is a Founding Director of the UCSF Oral AIDS Center (OAC), the Founding Chair of Global Oral Health Interest Group from the Consortium of Universities for Global Health, and the Founding President of Global Oral Health Inequalities Network of the International Association for Dental Research. He was co-PI of the UCSF site of the international oral AIDS program that was part of the NIAID-funded AIDS Clinical Trails Network (ACTG). He co-founded the on-going series of World Workshops on Oral AIDS in 1987 and led the first three Workshops and served on the leadership group of the subsequent four Workshops. He provides advice and support to many undergraduate and DDS/PhD students, as well as mentoring a number of junior and senior faculty members of the UCSF/Gladstone Institute of Immunology and Virology Center for AIDS Research Mentoring program. He has received numerous grants and honors, including John Greene Society Faculty Research Award, American Association of Dental Research (AADR) Distinguished Scientist Award, King’s College London Dental Institute Alumnus of the Year Award, American Dental Association Gold Medal for Excellence in Dental Research, and UCSF Academic Senate Faculty Research Lecture Award –Translational Science. He is listed in Who's Who in America since 1997.
Prof. Stephen J. Challacombe, BDS, Ph.D, FDSRCSEd, FRCPAth, FmedSci, FDSRCS. is a renowned researcher and clinical specialist in oral medicine. He is the Martin Rushton Professor of Oral Medicine in University of London & King’s College London. He is past President of the International Association for Dental Research (IADR) and current president of the Hunterian Society. He has had a long professional interest in the oral manifestations of HIV and on mucosal immunity in HIV which has led to over 25 research papers. He was part of the consensus meeting on the classification of the oral lesions in HIV in 1991 and 1993. Since 1996, He was the Co-chairman of International workshops on the oral manifestations of HIV infection in the UK, South Africa, Thailand, China, and India. From 2000-2017 he was Chairman of the International steering committee on Oral Health & Disease in HIV infection. He has been an author or co-author of over 240 peer-reviewed research papers and 160 other publications on Mucosal immunity; Immunological, dermatological and microbiological aspects of oral diseases; Oral medicine; Candida infections; Immunological aspects of Dental Caries, Oral manifestations of HIV infection, Oral Tolerance. Editor or co-editor of 9 books on Food Allergy, Food Allergy & Intolerance, Practical and Theoretical aspects of ELISA, Oral Aids Research, and Immunology of oral diseases. Early in his academic career he was an Assistant Professor & Senior Research Fellow in the Department of Immunology, Mayo Clinic, USA (1978-1979), and his career includes serving as Dean for International Affairs, KCL health Schools (2007-2012). He served as President of British Society for Oral Medicine (1995-1997), President of European Association of Oral Medicine (2008-2010), and from 2007- 2013, he was Chairman of the Expert Specialist Advisory Group for OHARA (oral section of Aids clinical trials group). In addition to all his tremendous activities related to oral health and diseases in HIV/AIDS, he also has extensive experience in administration which includes running the University departments, organising conferences, managing grants, budgets and research, teaching and clinical activities. He has received a number of awards for his research. Recently, he received a Samuel Charles Miller award from the American Academy of Oral Medicine.
Prof. Dr. Anwar R Tappuni, BDS, LDSRCS, Ph.D, MRACDS(OM) is Reader/Honorary Consultant/Academic Lead for Oral Medicine at the Queen Mary University of London, and the Director of Doctorate in Clinical Dentistry in Oral Medicine. She was the Honorary Professor in School of Dentistry, Saveetha University, India (2017). She has several high profile international and national roles including President of the Oral Medicine and Pathology Group from International Association for Dental Research, and President of the Oral Medicine and Pathology Group from British Society for Oral and Dental Research. She is also Chair of the BMA/BDA Refugee Doctors and Dentists Liaison Group. She is on the Medical Council and a Trustee for the British Sjögren’s Syndrome Association. She leads a successful multidisciplinary clinic with rheumatology consultants, providing specialized clinical service for Sjögren’s syndrome patients. She led on writing the National Treatment Guidelines for Treatment of Sjögren’s in Adults, which was ratified by the National Institute for Clinical Excellence, the British Society for Rheumatology, and The British Health Professionals in Rheumatology. She is the invited Editor for a Text Book on Sjögren’s Syndrome commissioned by Oxford University Press. She co-chaired the International Steering Committee and the meeting of the 7th World Workshop for Oral Health and Disease in AIDS (2014) in Hyderabad, India. She also co-authored the Hyderabad declaration which called for equal opportunities for HIV patients to access resources. She was Member of the Editorial Board of Journal of Dental Research, and Guest Editor for a Supplement of the Journal of Oral Diseases. She has developed and published a clinical tool for assessing the severity of oral ulcerative disease, which has been adopted for use in several clinical units and employed in clinical trials. She has been involved in developing severity scores for oral mucosal diseases and formulated an Ulcer Severity Score (USS) which has been validated and adopted by several Oral Medicine departments and proved to be valuable as an outcome measure in clinical trials. On her current research, she is investigating Sjögren's Syndrome from the safety and efficacy of the treatment, molecular imaging methods, risk factors, and other tests. She has been awarded the BDA Roll of Distinction for outstanding service to UK dentistry.
Melissa Riddle, Ph.D earned a doctorate in clinical psychology from the University of Arizona in 1998. Her doctoral research combined family therapy and behavioral medicine, asking questions related to how patients and their families manage chronic or serious illness. In 1998, Melissa started a 2 ½ year postdoctoral fellowship at the University of Pennsylvania. During this fellowship, her research and clinical care focused on the psychosocial effects of genetic testing for breast and ovarian cancer risk for women and their families. In 2001, Melissa joined the National Institute on Drug Abuse (NIDA), overseeing grants programs on behavioral treatments for drug abuse and HIV risk behavior. She joined the National Institute of Dental and Craniofacial Research (NIDCR) in 2007, where she has served as chief of the Behavioral and Social Sciences Research Branch (BSSRB) ever since.
Dr. Pandu Riono is a Senior Staff at University of Indonesia, Faculty of Public Health. He specializes in mathematical modeling of Infectious Diseases, including HIV/AIDS and Sexual Risk Network for HIV and STI, and also other infectious diseases. He was receiving some fellowships to study and attend the International Conference on Public Health issues. He was the recipient of Fogarty Fellowship to finishing his PhD in UCLA, 2001 with dissertation title is “Sexual Network among Men and STD/HIV Epidemic in Indonesia”. He was involved in the regional activities related with Risk Behavioral Analysis Workshop. He was Chair of Infectious Diseases Division Indonesian Medical Association Periode: 2003 - 2006 & 2006 – 2009. He was a Consultant for Asia-Pacific HIV-AIDS Data Hub, UNICEF Bangkok in 2007-2008. He also provides Technical consultants for HIV and Behavior Surveillance for MOH, including BSS among General Population in Papua. He is also the main editor for National HIV-AIDS related Risk Behavior Survey Reports since 2002, 2005, 2007, and until now. Since 2010, He was also appointed as Technical Consultant National TB Program, Developing National TB Estimation Methods. He is also a member of TB Operational Research Group – MOH and a member of AIDS Commission of Indonesian Medical Association. He has been appointed as International Consultant for WHO at Geneva.
Dr. Alice has worked on international gender and health issues for over 30 years. She is a trainer, writer, researcher and activist. After completing a PhD at Cambridge University, she lived and worked in rural areas of East, Southern and West Africa for several years, as an international development consultant. Diagnosed HIV positive in 1992, she wrote a training package on gender, HIV, communication and relationship skills called “Stepping Stones” (www.steppingstonesfeedback.org), now widely used across Africa, Asia, the Pacific, Latin America and beyond. It is one of the few programmes known to reduce intimate partner violence, which can be both a cause and a consequence of HIV.
Alice’s former positions include: former International Chair of the International Community of Women Living with HIV/AIDS; former member of the Leadership Council of the Global Coalition on Women and AIDS; former member of the UK Sexual and Reproductive Health and Rights Network steering committee; former member of the UNAIDS Global Dialogue Platform of women living with HIV; and former co-founder and co-chair (and now a patron) of the Sophia Forum, the UK Chapter of the Global Coalition on Women and AIDS.
Alice was one of 14 women to be honoured by the WorldYWCA in July 2007 with an award for innovative leadership in the global response to HIV. She received the honour of being elected as the first woman Alumnus of the Year for 2012 by Clare College, Cambridge University. Alice also holds an Honorary University Fellowship at Exeter University Medical School, England, where she is an occasional tutor in medical humanities to undergraduate medical students. In Spring 2015, she was honoured to be nominated as one of 300 women leaders in global health by the Global Health Programme at the Graduate Institute in Geneva. In December 2016, Alice became one of four new women to be made an Honorary Fellow of the Royal College of Obstetricians and Gynaecologists.
Anthony Santella, DrPH, MPH, MCHES is an Associate Professor of Public Health and LGBTQ+ Studies at Hofstra University in Long Island, New York. Long Island has the highest number of AIDS cases of any suburban area in the country and more cases than 26 states.
Dr. Santella also serves as Chair of the Long Island Ryan White HIV Planning Council, Governing Councilor of the HIV/AIDS Section of the American Public Health Association (APHA), Chair of the Committee on Health Equity of APHA, Associate Editor for Frontiers in Public Health, and Academic Editor for PLOS One. He also serves on the Board of Directors of The HIV League, a nonprofit organization which provides scholarships to people living with HIV pursuing a university degree.
Dr. Santella is a public health scientist and health services researcher specializing in HIV and STI prevention and sexual health. His research agenda focuses on the integration of primary and secondary prevention in clinical settings. Specifically, his work explores the role of dental professionals (dentists and dental hygienists) in conducting rapid HIV testing in the dental setting. Using qualitative, quantitative, and mixed-methods research he has led, co-led, and advised on projects conducted in the United States, United Kingdom, China, India, Vietnam, and Australia alongside in-country dental clinical and public health scholars. This research has been published in journals such as the Australian Dental Journal, British Dental Journal, Journal of Dental Hygiene, International Journal of Dental Hygiene, and Oral Health and Preventive Dentistry.
He has also received grants from the foundation, university, and government sectors and has presented his work at local, national and international conferences such as the American Public Health Association Annual Meeting, International AIDS Conference, and the International Association of Dental Research Annual Meeting. >
Dr. Santella earned a Bachelor of Science in Biomedical Sciences from the University of Connecticut (Storrs, Connecticut, US), a Master of Public Health in Health Policy and Management from Emory University (Atlanta, Georgia, US), a Doctor of Public Health in Health Systems Management from Tulane University (New Orleans, Louisiana, US), and an Advanced Certificate in Health Professions Pedagogy and Leadership from Hofstra University (Long Island, New York, US). He is also a Master Certified Health Education Specialist by the National Commission of Health Education Credentialing.
Sharof M. Tugizov, DVM, Ph.D, DSc has research focus is investigation of the interactions of human viruses, including human cytomegalovirus (HCMV), Epstein–Barr virus (EBV), Herpes simplex virus (HSV), human immunodeficiency virus (HIV), and human papillomavirus (HPV), with monostratified and multistratified oral epithelia. He has made significant contributions to current knowledge about entry, transcytosis, intracellular transport, egress, and cell-to-cell transmission of these viruses in oral epithelial cells by establishing and using polarized epithelial cells, as well as ex vivo oral mucosal tissue explants.
Prof. Deborah Greenspan, BDS, DSc. is one of the world’s leading investigators and clinicians in oral infectious diseases, especially in relation to HIV/AIDS. She has worked with colleagues throughout the world to improve oral and general health of this group of patients. Her international work includes training a generation of clinicians, many from resource poor countries, both in clinical care and in the development of research programs. She has made crucial discoveries concerning oral health, including delineating new lesions in association with HIV infection, for example her co-discovery of oral hairy leukoplakia, and new ways of treating the mouth problems in HIV positive people. She has charted the changes in the AIDS epidemic since its beginning in San Francisco. Her co-discovery of hairy leukoplakia opened up new aspects, not only of AIDS research worldwide but also in the field of Epstein-Barr virus research. Her group pioneered effective oral care for the millions of people worldwide with HIV infection, and set an example for delivery of dental care for that group. She led the UCSF School of Dentistry’s effort to establish new protocols to protect patients and health care providers against transmission of blood-borne infections. This example set the standard. She has made major contributions to improving oral health for people with oral cancer who have been treated with radiation therapy. She is an international leader in oral science and has spoken extensively on oral cancer, oral candidiasis, AIDS, the oral manifestations of HIV infection and infection control and has given many radio, television and print media interviews. She is Professor-Emerita of Oral Medicine and the past Chair of the Department of Orofacial Sciences at the University of California San Francisco, Past President of the International Association for Dental Research, former Chair of the San Francisco Division of the University of California Academic Senate 2005 to 2007. She is a Fellow of the American Association for the Advancement of Science and a member of the National Academy of Medicine. In 2000, she received the Silver Medal of the Ville de Paris, in 2004, Norton Ross Award from the American Dental Association, while in 2009 she received the Frederick Birnberg Award for Excellence in Dental Research from Columbia University College of Dental Medicine and in 2011 she received the Distinguished Scientist Award in Oral Medicine and Pathology from the International Association for Dental Research. The ScD (hc) was conferred on her by Georgetown University, the FDSRCS (Hon) by the Royal College of Surgeons of Edinburgh, in 2007 the DSc (hc) by Kings College, University of London, UK and in 2008, the DDS (hc) by the University of Sheffield UK. She received the Positive Health Practice Award of the 360 HIV/AIDS Clinic at UCSF in 2008 and in 2009 the Frederick Birnberg Award from Columbia University College of Dental Medicine, New York. She has been an Ambassador in Research America’s Paul G Roger’s Society for Global Health Research. She is a Fellow of the International College of Dentists and of the American College of Dentists.
Dr. Irna Sufiawati, drg., Sp.PM (K)., Ph.D is currently Associate Professor and Head of Oral Medicine Department at Faculty Dentistry University of Padjadjaran. She has been interested in the field of HIV/AIDS since she worked in Public Health Centre Wamena, Papua, East Indonesia, and decided to continues her education and research in infectious diseases. She had completed a sandwich Ph.D program in 2011 at the University California of San Francisco (UCSF), San Francisco, United States of America, majoring in Virology. Ever since, she dedicated herself in the area of HIV infections, which is a serious impediment for oral health in Indonesia. She is member of AIDS prevention and control commission in West Java-Indonesia and served as an oral and dental health coordinator and consultant in HIV/AIDS Clinic in the central reference Dr. Hasan Sadikin Hospital Bandung West Java that has become one of the provinces with the highest number of people living with AIDS in Indonesia. She has had invited as the main speaker in local and regional events, especially in the topics related to HIV and sexually transmitted diseases. She is a chairman of Indonesian Oral Medicine Association Region II and a curriculum coordinator of Indonesian Collegium of Oral Medicine. She has been awarded a number of honours since 12 years ago, such as the Best Research Award in the FDI World Dental Federation–Indonesian Dental Association Joint Meeting 2016, in Forsila III 2017, and in the International Conference on Biophysical Technology in Dentistry in conjunction with International Scientific Meeting in Dentistry 2018. Her research interests include the epidemiology, etiopathogenesis and management of oral diseases associated with HIV/AIDS, oral precancer and oral mucositis associated with cancer therapy, oral manifestation of autoimmune diseases especially lupus erythematosus, and salivary diagnostic. Alongside her teaching and research background, she has ample experience of effectively organising scientific conferences and workshops in the level of local and national in Indonesia.
Dr. Christopher Hughes Fox, MSc, MDSC is an Chief Executive Officer of the International Association for Dental Research and the American Association for Dental Research. He has been the PI of The 6th and 7th International Workshops on Oral Health and Diseases in AIDS held in China (2009) and India (2014), organised by the National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR). He is also the PI of an FDA conference grant on oral health effects of tobacco products, and currently PI of an NIH/NIDCR Bloc Travel Grant. He has extensive experience in organising both domestic and international scientific conferences. His early career focused on the epidemiology of the periodontal disease. However, having worked for a private multinational oral health consumer company, his research was broadened from clinical disease to translating research findings into practice behaviours. He is passionate about public policy being adequately informed by the latest available evidence and to identify research gaps where they exist, and to advocate for research funding to address those gaps – an area which certainly applies to oral health and disease in HIV/AIDS. Working with the IADR Board of Directors and other key stakeholders, he has brought attention to the need for research to inform the global oral health policy agenda and to address global oral health inequalities. He received many awards, including the Harvard School of Dental Medicine Distinguished Alumnus Award (2007). In the past three years, He was awarded a Fellow of American Association for Dental Research (2016) and American Academy for the Advancement of Science (2017). This year He received the Alan J. Davis/SCADA Achievement Award.
Prof. Dr. dr. Ketut Tuti Parwati Merati, SpPD-KPTI, FINASIM is professor of Medical Science, Internal medicine department. She is Head of Infection and Tropic disease Division RSUP Sanglah Denpasar, Bali and Lecturer Faculty of Medicine, Udayana University, Denpasar, Bali. In 1997, she is Consultant of Infection and Tropic disease. She is Founder and Chief of Citra Usadha Indonesia Foundation (YCUI), Chief of Forum Lembaga Peduli AIDS (FLPA) and Chief of PETRI (Perhimpunan Peneliti Penyakit Tropis dan Infeksi), Bali Branch.
Prof. David Michael Williams, BDS, MSc, Ph.D, MRCPath, FRCPath is Professor of Global Oral Health in Bart's and The London School of Medicine and Dentistry, Queen Mary, University of London. He was one of the founders of the International Association for Dental Research (IADR) Global Oral Health Inequalities Research Network and its President from 2014-17. He leads an international collaboration under the auspices of the World Dental Federation FDI and the International Consortium for Health Outcomes Measurement to develop clinical measures of oral health with patient-reported physiological and psychosocial measures. He was also the initiator of the IADR Global Oral Health Inequalities Research Agenda (GOHIRA) which aimed to reduce inequalities in oral health within a generation. Since 2014, He is Co-Chair of FDO Vision 2020 Think Tank, and He is Vice Chair of FDI Science Committee since 2015. He served as Dean of Faculty of Medicine, Health and Life Sciences and Professor of Pathology in the University of Southampton (2004-11). He received a number of honours, such as Distinguished Scientist Award, International Association for Dental Research (1996), and Honorary Fellow in Dental Surgery, Royal College of Surgeons of England (2008). He has been involved as Co-Organizer, and Member of the International Steering Committee in Workshops on Oral Aspects of HIV Infection since 1995, and He was the convening member of the international workshop that established the classification of oral mucosal lesions associated with HIV infection, which has been adopted universally in epidemiological studies of the disease.
Dr. Agnes Rengga Indrati, dr., M.Kes., Sp.PK(K) is Doctor in Clinical Pathology Departemen Hasan Sadikin Hospital. She is a Head of Clinical Pathology Specialist Program Faculty of Medicine University Padjajaran and a head of The Laboratories of “Klinik Teratai” (HIV/AIDS center Hasan Sadikin Hospital). Her research focuses on HIV, including Integration Management of Patient of HIV and AIDS Care and Treatment, HIV Receptors in people with HIV / AIDS Injecting Drug users, Methods of Diagnosing Interferon Gamma in the TB-SPOT Method in Patients with TB-HIV, Impact of Early HIV testing and therapy strategy interventions on gay and female sex worker populations in Indonesia, Cytokine Profile in Latent TB Patients with HIV, Expression of Human Immunodeficiency Virus Co-receptors CCR5 and CXCR4 on Lymphocyte T Subset and Monocyte.
Rudi Wisaksana, dr., Sp.PD-KPTI., PhD. He is the Head of Tropical and Infectious Diseases Division, Department of Internal Medicine, Faculty of Medicine Padjajaran University. He had completed the Ph.D Program at Radboud University Nijmegen, Netherlands. He leads some organization, including Head of HIV/AIDS Team, Hasan Sadikin Hospital Bandung, Indonesia; Head of Research and Development Working Group, West Java Provincial AIDS Commission, Bandung, Indonesia; Head of Tropical and Infectious Diseases Division, Department of Internal Medicine, Hasan Sadikin Hospital, Faculty of Medicine. He is a member of HIV Expert Panel on Operational Research, Ministry of Health, Indonesia and member of TB-HIV Working Group, Medical Faculty, Padjadjaran University Bandung, Indonesia. He received got some research grants, including joint rapid assessment on the strategic use of ART to reduce HIV related mortality and to prevent HIV transmission in Indonesia from National AIDS Commission, Ministry of Health, USAID. His major research interest is on the challenges in delivering HIV-care in Indonesia, and the barriers, challenges & good practices in delivering antiretroviral treatment.
Dr. I Dewa Made Sukrama, dr., M.Si., Sp. MK (K) He is Head of the Dentistry Program in the University of Udayana, Bali-Indonesia. He is also chairman of Association of Indonesian Microbiologist-Balinese branch, member of the research ethics committee of Faculty of Medicine-Sanglah Hospital. In 1985, He took his medical degree from the Faculty of Medicine, University of Udayana, and then continued his master degree in Immunology from University of Airlangga. Lastly, in 2009 He took his doctorate in University of Udayana. He has been a productive researcher with more than 16 topics mainly focusing on gut microbiota, probiotics, and the effects of herbal substances, such as The Kombucha, Mengkudu extract, Achatina fulica (mucus snail), and Euphorbia Milii Flower Extract in human immunity response.
Dr. dr. Ni Made Linawati, M.Si. She is currently Associate Professor in the Department of Histology and a Coordinator of the Dentistry Study Program at the University of Udayana. She received her medical degree from the University of Udayana and her master degree in immunology at University of Airlangga. She completed her doctorate in Biomedical science in 2007 at the University of Udayana. She is a member of Anatomy Expert Association of Indonesia (PAAI) and International Federation of Associations of Anatomists (IFAA). Her research interests focused on herbal medicine and the immunology of Mycobacterium tuberculosis.
Anandi Yuvaraj is an AIDS activist and HIV and SRHR consultant based in India. Anandi worked as a consultant with UNAIDS, India office supporting a multi-country project on Gender based Violence and HIV being implemented by research partners and CBOs and South to South Initiative. She is a member of International Community of Women Living with HIV (ICW Global). Anandi spearheaded the Asia Pacific Regional Chapter of ICW as Regional Coordinator from 2008-2012. During this period, she led community based research using PLHIV Stigma Index tool to measure the level of stigma experienced by PLHIV in Tamil Nadu and Northeast states with UNAIDS support. She was awarded a research project by ICMR to assess Sexual and Reproductive Rights of Women with HIV using quantitative methodology. Prior to joining ICW, Anandi worked as Program Manager for HIV and Sexual Reproductive Health at PATH’s India office, where she managed an advocacy project of the Global Campaign for Microbicides (GCM) in India. Anandi has served on many high level committees at the global level to scale up HIV programmes in developing countries. She also served as a steering committee member of UNAIDS second evaluation process in 2010. She was also employed by the International HIV/AIDS Alliance in India as Senior Programme Officer for over five years. During this tenure she got involved with the Global Fund fight for AIDS, TB and Malaria (GFATM) as the Board representative of the Communities Delegation (2004-06).
Prof. Paul Fidel, Jr. graduated from Allegheny College in Pennsylvania with a B.S. degree in Biology in 1984. He then attended the University of Oklahoma where he continued his studies, and received a M.S. in 1987 and Ph.D. in 1988 in the field of microbiology. He joined the Wayne State University School of Medicine in Detroit, Michigan as a postdoctoral fellow in the department of Immunology and Microbiology and was eventually appointed Assistant Professor of Medicine in the Department of Medicine, Division of Infectious Disease in 1990. In 1995, Dr. Fidel joined Louisiana State University Health Sciences Center in New Orleans as Associate Professor of Microbiology, Immunology, and Parasitology. He was granted tenure in 1997 and promoted to Professor in 1999. In 2001 Dr. Paul Fidel was named holder of the Carl Baldridge Chair in Oral and Craniofacial Biology and appointed the director of the Center of Excellence in Oral and Craniofacial Biology. Dr. Fidel has mentored numerous Ph.D students, medical/dental students, and junior faculty. He has authored over 160 publications and has served as Principal Investigator for over 20 research grants totaling over $30 million, 15 of which were from the National Institutes of Health. Dr. Paul Fidel’s research has greatly impacted the fields of medical mycology and infectious disease. Pioneering studies using novel mouse models and human clinical samples have defined unique paradigm-changing aspects of host-pathogen interactions in vaginal and oral candidiasis, including that in HIV disease. Current work focuses on the oral microbiome in HIV disease as well as continuing work in mucosal candidiasis.
David Moyes, BSc, MSc, PhD has an ongoing interest in the interactions between humans and the microbes that co-exist with us. In particular, he is interested in how we discriminate between harmless and harmful microbes and how this affects our general health. He is an experienced post-doctoral scientist with a strong background in research and have published regularly in international journals. He manages several research projects concurrently, coordinating with other members of his team as well as other groups both nationally and internationally. As well as research, He teaches and supervises both undergraduates and post-graduates and is involved in the administration of the department.
Dr Fiona M. Burns, PhD, FRCP, is HIV Clinical Lead at the Royal Free Hospital and an Associate Professor in Sexual Health and HIV at UCL. Her research interests are in the social and behavioural dimensions of HIV/STI epidemiology, with a particular interest in health care access, engagement and social inequalities, as well as migrant health. She sits on the BHIVA Executive committee and co-led on the BHIVA Standards of Care for people living with HIV 2018. She undertook her medical training at Otago University in New Zealand before moving to the UK in 1995.
Prof. Newell W. Johnson, CMG, FMedSci, FRCPath, FFOPRCPA, FDSRCS, FRACDS, MDSc, Ph.D, FHEA, FOMAA, FICD is currently Professor Emeritus at King's College London and at Griffith University, Queensland, Australia where has served as head of department and Foundation Dean of the dental school. He holds honorary appointments in numerous other universities across the globe. He has been researching and teaching oral/head and neck cancer for over half a century in all continents covering epidemiology, risk factors, diagnostics and treatment outcomes. Active work on HIV/AIDS dates from the early 1990s, in UK, Africa and especially in India. He practices clinical oral medicine and histopathology. Honours include Companion of St Michael and St George from HM Queen Elizabeth, Fellow of the Academy of Medical Sciences (UK) and Distinguished Scientist Award from the International Association of Dental Research.
He has published over 400 refereed papers and numerous books and book chapters covering head and neck oncology, HIV disease, diagnostic histopathology, clinical oral medicine, periodontology, cariology and dental education. Notable here is the second edition of his major text Oral and Oropharyngeal Cancer with Jatin Shah, published November 2018 https://www.crcpress.com/Oral-and-Oropharyngeal-Cancer/Shah-MD-FACS-Johnson-CMG-FMedSci-MDSc/p/book/9781498700085
He currently leads a team based in the Menzies Health Institute Queensland researching the above issues, with local collaborators, on projects in Australia, Papua New Guinea, India, Sri Lanka, Bangladesh, Saudi Arabia, Yemen, Kenya, Nigeria, Sudan, South Africa, and Colombia.
He has extensive experience as a supervisor of Higher Degree by Research students, having seen to completion over 20 PhD degrees.
He is a registered specialist in Australia in oral pathology, in oral medicine, and in periodontology.
NWJ November 2018
Jennifer Webster-Cyriaque, Ph.D, DDS is currently associated professor at University of North Carolina. In 1992 Undergraduate double major: Biology and Interdisciplinary Social Science, B.A. State University of New York at Buffalo Dental School (DDS) State University of New York. In 1998 reach Doctor of Philosophy (Ph.D) University of North Carolina Hill in Microbiology and immnunology, Postdoctoral Fellowship, Pathogenesis of Infectious Disease, University of North Carolina at Chapel Hill.
Prof. Julian Naglik graduated with a BSc from the University of East London in 1992 and obtained his Ph.D. from King’s College London in 2001, studying the expression of the secreted aspartyl proteinases in Candida albicans infections. He was appointed Lecturer in 2006, Reader in 2013 and Professor in 2016. Previously, he undertook roles as a visiting research scientist at the Robert Koch Institute (Berlin, Germany) as well as the University of California San Francisco (USA). Julian is currently Professor of Fungal Pathogenesis and Immunology in the Centre for Host-Microbiome Interactions, Faculty of Dental, Oral and Craniofacial Sciences at King’s College London. His current research projects relate to the molecular analysis of host-pathogen interactions at mucosal surfaces, with specific focus on epithelial mechanisms activated by the human fungal pathogen C. albicans. His laboratory described the danger response signalling pathways activated by the invasive hyphal form of C. albicans, which recently was found to be due to the secretion of candidalysin. Candidalysin is the first cytolytic peptide toxin identified in any human fungal pathogen and has been recognised as a seminal advance in the microbiology field. His research is supported by grants from the Medical Research Council (MRC), Biotechnology & Biological Sciences Research Council (BBSRC), National Institutes of Health (NIH) and the Wellcome Trust. Professor Naglik’s research has received awards from King's College London, the German Mycological Society, Heinz Maurer-Prize award, and the German Society for Hygiene and Microbiology. He is also an Honorary Member of the British Society of Medical Mycology.
Dr. Weinberg is a tenured professor in the School of Dental Medicine, chairs its Department of Biological Sciences, and is the School's Associate Dean for Research. He is secondarily appointed in the Department of Pathology and in the Proteomics and Bioinformatics Core in the School of Medicine. He teaches oral microbiology and immunology to dental students and residents. Dr. Weinberg mentors junior faculty and assists them in their research.
Dr. Weinberg's research focuses on innate immune responses of mucosal epithelium to bacteria, fungi, and viruses. Throughout his research career, Dr. Weinberg has combined his clinical background with cutting-edge molecular and cellular biological approaches to research oral diseases.
Dr. Lauren L. Patton is Professor and Chair of the Department of Dental Ecology at the University of North Carolina at Chapel Hill (UNC) School of Dentistry and Director of the General Practice Residency (GPR) program. She is a Fellow of the American Association of Hospital Dentistry and Diplomate of the American Board of Special Care Dentistry. Current President-elect of the American Academy of Oral Medicine (AAOM), she is a Diplomate and past President of the American Board of Oral Medicine. She earned her DDS at the University of North Carolina, attended the 2-year GPR at UNC, followed by a 2-year Clinical Dental Staff Fellowship with Oral Medicine/Research training at the National Institute of Dental and Craniofacial Research (NIDCR) in Bethesda, MD. During her 28 years on UNC faculty, she has conducted industry and federal government–funded clinical and health services research; participated in teaching at dental hygiene, dental, and post-doctoral levels; published over 140 papers, monographs and book chapters; and lectured internationally on oral manifestations and management of patients with medical complexities, such as HIV/AIDS and oral cancer. In 2013, she received the AAOM’s Samuel Charles Miller Award for Significant Contributions to the Science, Literature, and Patient Care in the Field of Oral Medicine. She serves as a member of the American Dental Association (ADA) Council on Scientific Affairs and is editor of The ADA Practical Guide to Patients with Medical Conditions. She also serves as the Oral Medicine Section Editor of Oral Surg Oral Med Oral Pathol Oral Radiol. She is the UNC site Principal Investigator of the NIDCR-funded Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
Dr. Velia Ramirez-Amador is Full-Time Researcher-Professor at the Universidad Autonoma Metropolitana-Xochimilco (UAM-X), Mexico City and Founder and Ex-Director of Studies of the Master Course in Oral Pathology and Oral Medicine at the UAM-X, Mexico City. Member of the National System of Research (National Council in Science and Technology), MEXICO.
Dental Surgeon at the Universidad Nacional Autonoma de México. Master in Science (MSc) in Oral Pathology at the Institute of Dental Surgery, Eastman Dental Hospital, University of London, England. Doctorate (PhD) in Oral Pathology, University of Sheffield, England. Post-doctoral Visiting Associate Professor at the Division of Oral Medicine, Pathology and Radiology. Universidad de California, San Francisco CA, USA.
70 scientific articles, 12 chapters in scientific books and more than 300 presentations in specialized Congresses.
Research interests: Oral manifestations on HIV/AIDS, since 1990 and oral cancer, since 1973.
Ian Needleman BDS, MSc, PhD, MRDRCS(Eng), FDSRCS(Eng), FHEA
Ian is Professor of Periodontology and Evidence-Informed Healthcare at University College London, Eastman Dental Institute. He leads the Centre for Oral Health and Performance (www.ucl.ac.uk/cohp) which was awarded recognition by the International Olympic Committee as part of the UK Research Centre for prevention of injury and protection of athlete health in collaboration with the Institute of Sport Exercise and Health and the National Centre for Sport and Exercise Medicine. His research has been awarded prizes by the European Federation of Periodontology, Royal Society of Medicine, German Periodontal Society, German Cochrane Centre and International Association for Dental Research. Ian was a member of the International Olympic Committee, Scientific Committee for the 2014 Conference on Prevention of Injury and Illness in Monaco and a Faculty member for 2017. He was awarded the UCL Provost’s Prize for Institutional Leadership in Public Engagement in 2017. Ian is highly active within patient and public involvement in research. He set up and leads the Patient Forum for the British Society of Periodontology as well as the PPI Forum for Oral Health in the UCL/UCLH Biomedical Research Centre. Ian is a member of the advisory group of the new UCL Centre for Co-Production in Health Research which is developing new methods to strengthen the position of the public within healthcare research.
Alice Welbourn, Ph.D, FRCOG (Hon) has worked on international gender and health issues for over 30 years. She is a trainer, writer, researcher and activist. After completing a PhD at Cambridge University, she lived and worked in rural areas of East, Southern and West Africa for several years, as an international development consultant. Diagnosed HIV positive in 1992, she wrote a training package on gender, HIV, communication and relationship skills called “Stepping Stones” (www.steppingstonesfeedback.org), now widely used across Africa, Asia, the Pacific, Latin America and beyond. It is one of the few programmes known to reduce intimate partner violence, which can be both a cause and a consequence of HIV.
Professor Wipawee Nittayananta is a Professor of Oral Medicine, Thammasat University, Pathum Thani, Thailand. She graduated from the Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand in 1989. She was a scholar of the German Academic Exchange Service (Deutscher Akademischer Austausch Dienst; DAAD) to study at the Freie Universität Berlin, Germany, and obtained a degree of Dr. med. dent. in 1994. In 2002, she received a scholarship from the US Fogarty International Center/National Institute of Health to study at the University of Washington, Seattle, USA. She was in a combined program of Oral Medicine and Oral Biology, and obtained her master degree in Oral Medicine in 2005 and a PhD degree in Oral Biology in 2006. Prof. Nittayananta currently serves in Editorial Board of various international journals including Oral Diseases, Journal of Investigative and Clinical Dentistry, and World Journal of Stomatology. Prof. Nittayananta has also been invited to join the World Health Organization (WHO) Taskforce Group on Oral Health in HIV/AIDS since 2005. Her fields of interest in research involve oral mucosal lesions, innovation for oral health, and mucosal innate immunity. She has been a reviewer of various international journals, including Oral Diseases, Journal of Oral Pathology and Oral Medicine, and Archives of Oral Biology, and edited different books such as “Oral Manifestations of HIV Infection”, and “Common Oral Lesions and Orofacial Pain”. Prof. Nittayananta received The 2013 Best Reviewer Award from Oral Diseases.
Dr. Venkatesan Chakrapani, MD, PhD. is Wellcome/DBT India Alliance Senior Fellow, School of Public Health, PGIMER, Chandigarh; and Chairperson of Centre for Sexuality and Health Research and Policy (C-SHaRP), a not-for-profit research agency in Chennai. He has more than 15 years of experience in conducting applied and policy-oriented health research among marginalised communities such as men who have sex with men, transgender people and people living with HIV. His studies have provided evidence base on: stigma/discrimination and structural violence; barriers to HIV prevention/treatment services and gender transition; social/sexual networks and sexual risk; impact of sexual minority stigma on mental health and HIV risk, syndemics and HIV risk; and acceptability of new HIV prevention technologies. He has received several fellowships including NIH Fogarty fellowship at Yale University, USA; and the Fund for Leadership Development fellowship of the MacArthur Foundation. He has authored/co-authored 43 peer-reviewed journal articles, more than 50 technical/policy reports and five book chapters.
Dr. David Reznik is the founder and Director of the Oral Health Center of Grady Health System’s Infectious Disease Program. He also serves as Chief of the Dental Service for the Grady Health System and is an assistant clinical professor at Emory University School of Medicine. He is President of HIVDent (HIV Dent Alliance), a not-for-profit organization of concerned healthcare providers committed to assuring access to high quality oral health care services for people living with HIV disease. Dr. Reznik also serves as Dental Director for both the Southeast AIDS Training and Education Center and the Mountain Plains AIDS Education and Training Center. Dr. Reznik was a member of the Presidential Advisory Council on HIV/AIDS and was honored at the 2008 Ryan White All Grantees meeting with the HRSA – HIV/AIDS Bureau – Associate Administrator’s Award: “For his years of passion, dedication commitment and national leadership on HIV oral health care, and for serving as a champion for national health care provider education.”
Dr. Ravi Verma is Regional Director for the International Center for Research on Women’s (ICRW) Asia Regional Office in New Delhi, India, Dr. Ravi Verma leads ICRW’s local and regional efforts to conduct research, provide technical support, build capacity and partake in policy dialogue on an array of issues, including reproductive health, family planning, preventing domestic violence, child marriage, engaging men and boys to empower women, HIV/AIDS and economic development. He is passionate about grounding his work in gender equality with special emphasis on men and masculinities, reproductive health, HIV/AIDS and child marriage. At ICRW, he led the groundbreaking Gender Equity Movement in Schools (GEMS) program, which aimed to reduce violence and promote equitable gender norms among boys and girls ages 12-18 in Mumbai schools. The same program is been expanded in Bangladesh and Vietnam and also in other states of India. Under his guidance, ICRW adapted and evaluated a program “Coaching Boys into Men”, which aimed to reduce gender-based violence by working with men and boys through sports.
Pushpa Pandiyan, Ph.D is assistant Professor, Biological Sciences, School of Dental Medicine. She has finished Postdoctoral Fellowship, National Academy of Sciences in 2009. She is studying the mechanisms by which unwanted immune responses are regulated and focusing on how regulatory T cells (Tregs) and cytokine networks control inflammatory cells in different disease settings. Her Specialties is mucosal Immunity/Autoimmunity- Role of cytokine feedback regulation and TLR signaling in Treg/Th17 homeostasis, differentiation and plasticity
Dr. Annapurna Vyakarnam is Visiting Professor Centre for Infectious Disease Research Indian Institute of Science, CV Raman Avenue, Bangalore, India and Adjunct Professor at St John’s Research Institute St John’s Hospital Medical School, Bangalore & National Institute for TB Research, Chennai, India. Her laboratory probes host pathogen interactions and adaptive immunity pertinent to human immunodeficiency virus (HIV) and HIV-tuberculosis (TB) coinfection. Specifically she focus on understanding CD4 T cell function, which is a key orchestrator of immunity to both HIV and Mycobacterium tuberculosis (Mtb) and plays a central role in disease process. Tuberculosis (TB) is the most important opportunistic infectious disease in HIV infected subjects, especially in TB endemic areas, like India and South Africa. TB in these patients may result from reactivation of latent infection or from new infection. While most opportunistic infections tend to present late in the course of HIV infection when CD4 T cell counts have declined, the risk of TB is substantially increased at all stages of HIV infection including those with preserved CD4 T cell counts. Consequently, HIV infection has dramatically increased TB incidence globally. Given the global increase in multidrug resistant (MDR) TB, there is strong consensus in the scientific community and funding bodies of the need to improve our understanding of the mechanisms that drive selective early presentation of TB in HIV+ve patients and the associated need to develop effective therapeutic strategies in the treatment of HIV-TB coinfection.
Dr. Joel Palefsky is an expert in infectious diseases and in cancers associated with these diseases. His expertise includes treating anal dysplasia, a precancerous condition that may lead to anal cancer and that is caused by the human papillomavirus (HPV). Palefsky studies the biology of HPV and the Epstein-Barr virus, and is active in the development of new treatments. Palefsky earned his medical degree at McGill University and completed a fellowship in infectious disease at Stanford University. Palefsky is founder and president of the International Anal Neoplasia Society and president-elect of the International Papillomavirus Society.
Prof. Stina Syrjänen is professor at University of Turku. She has done high-level research on diseases such as human papillomavirus (HPV) in the head and neck and genital area. In 1983, her team first discovered in the world that HPV infection can cause cancer of the head and neck, in addition to genital cancer. Over the past ten years, the research team has been investigating, in particular, the ways in which HPV infection is transmitted, especially the significance of HPV infection in childhood for immunity and for the chronicisation of infection. They have also been the first in the world to investigate the natural course of oral HPV infection and factors affecting the healing and chronicisation of infection in women, men and children. There have also been other initial findings in Syrian research careers; his research team has found, for example, that herpes simplex virus 1 (HSV-1) that causes cough infection is also hidden in epithelial cells and not only in nerve tissue.
Dr. Gabriela Anaya Saavedra, Ph.D is a versatile writer and researcher that published extensively in specialized field. She is working in Universidad Autónoma Metropolitana-Xochimilco, Mexico. Her Research interest in Oral Pathology, Tuberculosis, Oral Cancer, Oral Surgery, Cancer Biology, HIV Infection, Epigenetics Cancer Immunology, Oral and Maxillofacial Surgery, Viral Load, Cancer Diagnostics, Pathology, TB-HIV, Stata Software.
David is a London-based general dental practitioner. He combines a knowledge of dentistry and communication skills together with 17 years of dentolegal and risk management experience.
He was co-founder and clinical lead for Chelsea and Westminster Dental Clinic for patients with HIV (1986-2006). In 2000 David was appointed as a dentolegal adviser for Dental Protection, the UK’s leading indemnity organisation, providing support on five continents to dentists facing regulatory and legal challenges. He later became Dental Communications Manager for the organisation (2007-2018).
David is a published author and has worked as both a journalist and editor-at-large in the UK since 1993 to the present day; Dental Practice; Editorial Board (1988-2010) Postgraduate Dentist Middle East; Editor (1989-97) hivdent.com; Advisory Panel (1997-present). He is a member of the British Dental Editors Forum.